Plunkett Research Online: Synairgen

SYNAIRGEN (SYGGF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmo.....



Synairgen
Ticker: SYGGF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 2380512800
Fax: 44 2380512800
Address: Southampton General Hospital, Tremona Road
Mailpoint 810, Level F, South Block
Southampton, SO16 6YD United Kingdom

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing

Ranks not available
Contacts Description
Richard MarsdenCEO/Director
Joseph ColliverCFO/Director
See More
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmo.....See More See More

Auditor: BDO LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (GBP)Bonus (GBP)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: